secwatch.observer — SEC 8-K summary
======================================

Issuer:     ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
CIK:        0001688757
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001688757-24-000071
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Establishment Labs Q2 revenue $44.1M, loss narrows; FDA PMA inspection completed
--------------------------------------------------------------------------------

- Q2 revenue $44.1M vs $48.6M YoY; gross margin improved to 65.6% from 62.3%.
- Operating loss $9.3M vs $13.7M loss YoY; adjusted EBITDA loss $4.3M vs $9.3M.
- Net loss $17.2M; cash $54.6M, up $14.6M from Dec 2023.
- FY2024 revenue guidance reaffirmed $174M-$184M (+5-11% YoY).
- FDA completed PMA preapproval inspection July 26; Motiva Implants US approval expected soon.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1688757/000168875724000071/0001688757-24-000071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1688757/000168875724000071/esta-20240806.htm
  HTML page:      https://secwatch.observer/filing/0001688757-24-000071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer